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Background
Children with juvenile spondyloarthropathy (jSpA), clas-
sified as enthesitis-related arthritis (ErA), under the ILAR
classification, usually experience both arthritis and
enthesitis. Therapeutic value of low-energy lasers (LLLT)
for enthesitis has not been systematically studied in chil-
dren with JIA.
Patients and methods
In this pilot study we report 20 children with jSpA, diag-
nosed based on both ESSG and ILAR criteria, which we
treated, in addition to standard NSAID therapy, with
LLLT. We used gallium-aluminium-arsenide (Ga-Al-As)
continued laser (Iskra Medical, Slovenia). The usual loca-
tion of treatment was AC joints, infrapatelar and/or Achil-
les' tendon insertions. The effects of therapy were
determined using the 100 mm VAS scale for pain reported
by patient, before, and 1 month after the therapy. Usual
therapy consisted of 10-minute sessions on 10 consecu-
tive days.
Results
There were 12 girls and 8 boys, medium age 11.4 yrs.
(range 7–17). The mean VAS before the therapy was 6.1
(range 4–8) and one month after the therapy was 1.3
(range 0–4). The usual dose used was between 2.5–3 J/m3
based on localization of enthesitis.
Conclusion
The biostimulating effect of LLLT is in its anti-inflamma-
tory, analgesic and anti-edematous effect on tissues. It
seems that Ga-Al-As laser therapy is a valuable addition to
the standard treatment modalities currently used for pain
and inflammation treatment of enthesitis in children with
jSpA. New patient enrolment and the correlation with six
core outcome variables is underway.
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